A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
Clinical trial NCT04192344 · RECRUITING
Trial details
- NCT number
- NCT04192344
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-20
- Primary completion
- 2026-12-31
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.